Retatrutide, by Soma Chems , represents a exciting advance in metabolic regulation. This unique compound combines GLP-1 receptor properties with GIP receptor agonist stimulation , indicating impressive efficacy in patient studies for body loss . Experts believe the drug is expected to offer a new solution for patients struggling with obesity issues